From: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
Tumor details
n
(%)
Stage
 I
15
11.3%
 II
55
41.6%
 III A/B
39
29.5%
 III C
23
17.4%
Grade
 1
10
7.6%
 2
53
40.1%
 3
69
52.3%
T
37
28%
58
43%
34
25.7%
 4
3
2.3%
N
 0
25.8%
46
34.8%
29
21%
14.4%